Multiple studies suggest that phenytoin concentrations increase with CBZ co-medication. This study evaluated the hypothesis that CBZ and/or its major metabolite (CBZE) inhibit CYP2C19-mediated phenytoin metabolism using human liver microsomes and cDNA-expressed CYP2C19. Oxcarbazepine (OXC), and its 10-monohydroxy metabolite (MHD) were also evaluated. CBZ and MHD inhibited CYP2C19-mediated phenytoin metabolism at therapeutic concentrations. Thus, administration of CBZ and OXC with CYP2C19 substrates with narrow therapeutic ranges should be done cautiously.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0920-1211(02)00188-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug-drug interaction of phenytoin sodium and methylprednisolone on voriconazole: a population pharmacokinetic model in children with thalassemia undergoing allogeneic hematopoietic stem cell transplantation.
Eur J Clin Pharmacol
December 2024
Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Purpose: Voriconazole (VRC) is recommended for the prevention and treatment of invasive fungal infections in children undergoing hematopoietic stem cell transplantation (HSCT). It demonstrates nonlinear pharmacokinetics (PK) and exhibits substantial inter- and intraindividual variability. Phenytoin sodium (PHT) and methylprednisolone (MP) are commonly used in the early stages of HSCT to prevent epilepsy and graft-versus-host disease.
View Article and Find Full Text PDFA Prospective Cohort Study on the Effect of Antiseizure Medications on Thyroid Function in Children Aged 6 Months to 12 Years with Epilepsy.
Sultan Qaboos Univ Med J
November 2024
Department of Pediatrics, Mediclinic City Hospital, Mohammed Bin Rashid University of Medicine & Health Sciences, Dubai, UAE.
Objectives: This study aimed to explore the effect of antiseizure medications (ASM) on thyroid function in children with epilepsy.
Methods: A prospective study involving children between 6 months and 12 years of age with new-onset seizures who took ASM within 2 months was conducted in the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India, between August 2019 to March 2022. Thyroid function tests-free T3, free T4 and thyroid stimulating hormone (TSH)-were done at baseline and after completing 3 months by competitive immunoassay using direct chemiluminescent technology.
Protocol for Therapeutic Drug Monitoring Within the Clinical Range Using Mid-infrared Spectroscopy.
Anal Chem
December 2024
School of Physics Engineering and Technology, University of York, Heslington, York YO10 5DD, U.K.
Therapeutic drug monitoring (TDM), which involves measuring drug levels in patients' body fluids, is an important procedure in clinical practice. However, the analysis technique currently used, i.e.
View Article and Find Full Text PDFThe role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy.
Front Pharmacol
October 2024
Department of Neurology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Article Synopsis
- Antiseizure medications, like valproic acid (VPA), show different results in patients due to genetic factors, though there's limited research specifically on VPA compared to other drugs.
- This study aimed to analyze how genetic variations influence the effectiveness, side effects, and serum levels of VPA in patients with genetic generalized epilepsies (GGE).
- The results revealed that certain genetic variants are linked to treatment failure, increased serum levels, weight gain, and hair loss among GGE patients using VPA, suggesting a need for personalized medication approaches.
Factors associated with subtherapeutic levels of valproic acid in hospitalized patients with epilepsy: A retrospective cohort study.
Medicine (Baltimore)
November 2024
Department of Pharmacy, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.
Article Synopsis
- Valproic acid (VPA) is an effective and cost-effective anti-seizure medication, but maintaining proper serum levels is critical due to its narrow therapeutic window.
- A study at a hospital found that 63.2% of patients had subtherapeutic VPA levels (<50 mg/L), with factors such as male gender, previous phenytoin use, and lower dosages increasing this risk.
- Findings highlight the need for careful monitoring and personalized treatment strategies to ensure effective VPA levels, with calls for further research on minimizing the risk of subtherapeutic levels.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!